Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO) Revenue
Annual & quarterly revenue history · segment & region breakdown
TMO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsThermo Fisher Scientific Inc. trailing twelve-month (TTM) revenue is $45.20B, an increase of 3.91% year-over-year from $44.56B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $44.56B | +$1.68B | +3.91% |
| 2024-12-31 | $42.88B | +$0.02B | +0.05% |
| 2023-12-31 | $42.86B | -$2.06B | -4.58% |
| 2022-12-31 | $44.91B | +$5.70B | +14.55% |
| 2021-12-31 | $39.21B | +$6.99B | +21.71% |
| 2020-12-31 | $32.22B | +$6.68B | +26.14% |
| 2019-12-31 | $25.54B | +$1.18B | +4.86% |
| 2018-12-31 | $24.36B | +$3.44B | +16.45% |
| 2017-12-31 | $20.92B | +$2.64B | +14.47% |
| 2016-12-31 | $18.27B | +$1.31B | +7.71% |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare TMO revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Thermo Fisher Scientific Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Thermo Fisher Scientific Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Thermo Fisher Scientific Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
TMO revenue · 4 questionsTMO's trailing twelve-month (TTM) revenue is $45.20B. That is an increase of 3.91% year-over-year from $44.56B in FY2025.
▸ Source: FMP · Thermo Fisher Scientific Inc. SEC filings · GAAP · Thermo Fisher Scientific Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026